Summit Therapeutics Inc.
Balance Sheet
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Assets | |||||||
| Cash & Equivalents | $225.3M | $104.9M | $71.4M | $348.6M | $71.8M | $66.4M | $63.8M |
| Accounts Receivable | — | — | $0 | $349.0K | $1.5M | $331.0K | $541.0K |
| Inventory | — | — | — | — | — | — | — |
| Total Current Assets | $720.3M | $423.8M | $189.7M | $656.7M | $97.3M | $87.7M | $79.6M |
| Property, Plant & Equipment | $1.1M | $254.0K | $204.0K | $906.0K | $694.0K | $725.0K | $518.0K |
| Goodwill | $2.0M | $1.9M | $1.9M | $1.8M | $2.0M | $2.0M | $2.0M |
| Intangible Assets (Excl. Goodwill) | — | $0 | $0 | $0 | $10.4M | $11.5M | $13.1M |
| Total Assets | $751.2M | $435.6M | $202.9M | $664.2M | $113.4M | $102.5M | $96.2M |
| Liabilities | |||||||
| Accounts Payable | $20.3M | $4.6M | $2.7M | $355.0K | $4.4M | $6.1M | $4.5M |
| Total Current Liabilities | $73.0M | $41.7M | $20.4M | $38.8M | $25.6M | $19.9M | $13.8M |
| Long-Term Debt | — | — | — | — | — | — | — |
| Total Liabilities | $92.3M | $46.8M | $125.3M | $537.5M | $30.1M | $23.0M | $17.4M |
| Stockholders' Equity | |||||||
| Retained Earnings | $-2.29B | $-1.21B | $-993.3M | $-378.3M | $-299.5M | $-210.9M | $-158.2M |
| Total Stockholders' Equity | $658.9M | $388.7M | $77.7M | $126.7M | $83.3M | $79.5M | $78.9M |